Status:
UNKNOWN
Risk Factors of Thrombocytopenia In Chronic Kidney Disease And Hemodialysis Patients In Assiut University Hospitals
Lead Sponsor:
Assiut University
Conditions:
Thrombocytopenia in CKD
Eligibility:
All Genders
18+ years
Brief Summary
factors contributing to thrombocytopenia in ESRD include uremia, blood loss, sepsis, and heparin treatment (2). Haemodialysis (HD) has been also identified as a potential cause of thrombocytopenia du...
Detailed Description
Thrombocytopenia is defined as a platelet count below 150,000/mm3 and can result from decreased platelet production, increased platelet destruction, or splenic sequestration. The severity of thrombocy...
Eligibility Criteria
Inclusion
- .Patient age between 18: 70 years old 2 .CBC with platelet count less than (80,000- 150,000) 3 .Hemodialysis duration \> 6 months
Exclusion
- .Decompensated liver disease. .known patients with idiopathic thrombocytopenia by bone marrow studies.
- Known patients with multiple myeloma and blood malignancies ( leukaemia ,, lymphoma
- Systemic lupus eryrthomatosis patients .Acute kidney injury patients .
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT06163144
Start Date
December 1 2023
End Date
December 31 2024
Last Update
December 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.